Skip to main content

Table 1 Patients’ characteristics

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Characteristics Number (%) / Median (range)
Age    57 (19–86)
FIGO  
I   42 (25%)
II   10 (5.95%)
III   103 (61.31%)
IV   13 (7.74%)
Histology   
Serous   124 (73.81%)
Endometrioid   18 (10.72%)
Clear cell   10 (5.95%)
Mucinous   4 (2.38%)
Nondifferentiated   4 (2.38%)
Mixed   8 (4.76%)
Grade   
1   16 (9.52%)
2   35 (20.83%)
3   117 (69.65%)
Cytoreduction   
R0   116 (69.05%)
R1 (≤ 1 cm)   29 (17.26%)
R2 (>  1 cm)   23 (13.69%)
Neoadjuvant chemotherapy    26 (15.48%)
Bevacizumab    32 (19.05%)
CA-125 before therapy    229.20 U/ml
(3.80–6000 U/ml)
Nadir CA-125 after therapy    10 U/ml
(2.70–35 U/ml)